ROCKWELL MEDICAL, INC. Cost of Goods Sold (Deprecated 2018-01-31)
ROCKWELL MEDICAL, INC. (RMTI) reported Cost of Goods Sold (Deprecated 2018-01-31) of $15.67 million for the 3-month period ending 2018-03-31, per its 10-Q/A filed 2018-08-14.
Discontinued › Expense Statement
us-gaap:CostOfGoodsSold · last filed 2018-08-14
- ROCKWELL MEDICAL, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $15.67M, a 28.07% increase year-over-year.
- ROCKWELL MEDICAL, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $16.06M, a 40.88% increase year-over-year.
- ROCKWELL MEDICAL, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $13.56M, a 20.66% increase year-over-year.
- ROCKWELL MEDICAL, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $11.74M, a 1.82% decline year-over-year.
- ROCKWELL MEDICAL, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $53.60M, a 15.19% increase from fiscal 2016.
- ROCKWELL MEDICAL, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $46.53M, a 0.26% increase from fiscal 2015.
- ROCKWELL MEDICAL, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $46.41M, a 1.69% increase from fiscal 2014.
- ROCKWELL MEDICAL, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $45.64M, a 0.17% decline from fiscal 2013.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 3 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|---|
| 2018-03-31 | $15.67M 10-Q/A · filed 2018-08-14 | $14.92M 10-Q · filed 2018-05-10 | $31.73M derived: sum of 2 quarters · filed 2018-08-14 | $45.29M derived: sum of 3 quarters · filed 2018-08-14 | $57.03M derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-12-31 | $16.06M 10-K · filed 2018-03-15 | $29.62M derived: sum of 2 quarters · filed 2018-03-15 | $41.36M derived: sum of 3 quarters · filed 2018-03-15 | $53.60M 10-K · filed 2018-03-15 | |
| 2017-09-30 | $13.56M 10-K · filed 2018-03-15 | $25.30M derived: sum of 2 quarters · filed 2018-03-15 | $37.54M 10-Q · filed 2017-11-08 | $48.94M derived: sum of 4 quarters · filed 2018-08-14 | |
| 2017-06-30 | $11.74M 10-K · filed 2018-03-15 | $23.98M 10-Q · filed 2017-08-09 | $35.38M derived: sum of 3 quarters · filed 2018-08-14 | $46.62M derived: sum of 4 quarters · filed 2018-08-14 | |
| 2017-03-31 | $12.23M 10-Q/A · filed 2018-08-14 | $23.64M derived: sum of 2 quarters · filed 2018-08-14 | $34.87M derived: sum of 3 quarters · filed 2018-08-14 | $46.83M derived: sum of 4 quarters · filed 2018-08-14 | |
| 2016-12-31 | $11.40M 10-K · filed 2018-03-15 | $22.64M derived: sum of 2 quarters · filed 2018-03-15 | $34.60M derived: sum of 3 quarters · filed 2018-03-15 | $46.53M 10-K · filed 2018-03-15 | |
| 2016-09-30 | $11.23M 10-K · filed 2018-03-15 | $23.20M derived: sum of 2 quarters · filed 2018-03-15 | $35.13M 10-Q · filed 2017-11-08 | $47.21M derived: sum of 4 quarters · filed 2018-03-15 | |
| 2016-06-30 | $11.96M 10-K · filed 2018-03-15 | $23.90M 10-Q · filed 2017-08-09 | $35.97M derived: sum of 3 quarters · filed 2018-03-15 | $47.85M derived: sum of 4 quarters · filed 2018-03-15 | |
| 2016-03-31 | $11.93M 10-K · filed 2018-03-15 | $24.01M derived: sum of 2 quarters · filed 2018-03-15 | $35.88M derived: sum of 3 quarters · filed 2018-03-15 | $46.77M derived: sum of 4 quarters · filed 2018-03-15 | |
| 2015-12-31 | $12.08M 10-K · filed 2017-03-15 | $23.95M derived: sum of 2 quarters · filed 2017-03-15 | $34.84M derived: sum of 3 quarters · filed 2017-03-15 | $46.41M 10-K · filed 2018-03-15 | |
| 2015-09-30 | $11.88M 10-K · filed 2017-03-15 | $22.76M derived: sum of 2 quarters · filed 2017-03-15 | $34.34M 10-Q · filed 2016-11-07 | $46.21M derived: sum of 4 quarters · filed 2017-03-15 | |
| 2015-06-30 | $10.89M 10-K · filed 2017-03-15 | $22.46M 10-Q · filed 2016-08-09 | $34.33M derived: sum of 3 quarters · filed 2017-03-15 | $45.81M derived: sum of 4 quarters · filed 2017-03-15 | |
| 2015-03-31 | $11.57M 10-K · filed 2017-03-15 | $23.44M derived: sum of 2 quarters · filed 2017-03-15 | $34.92M derived: sum of 3 quarters · filed 2017-03-15 | $45.93M derived: sum of 4 quarters · filed 2017-03-15 | |
| 2014-12-31 | $11.87M 10-K · filed 2016-02-29 | $23.35M derived: sum of 2 quarters · filed 2016-02-29 | $34.36M derived: sum of 3 quarters · filed 2016-02-29 | $45.64M 10-K · filed 2017-03-15 | |
| 2014-09-30 | $11.47M 10-K · filed 2016-02-29 | $22.49M derived: sum of 2 quarters · filed 2016-02-29 | $33.77M 10-Q · filed 2015-11-09 | $45.68M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-06-30 | $11.01M 10-K · filed 2016-02-29 | $22.30M 10-Q · filed 2015-08-04 | $34.20M derived: sum of 3 quarters · filed 2016-02-29 | $45.66M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-03-31 | $11.28M 10-K · filed 2016-02-29 | $23.19M derived: sum of 2 quarters · filed 2016-02-29 | $34.65M derived: sum of 3 quarters · filed 2016-02-29 | $45.95M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2013-12-31 | $11.90M 10-K · filed 2015-03-03 | $23.37M derived: sum of 2 quarters · filed 2015-03-03 | $34.66M derived: sum of 3 quarters · filed 2015-03-03 | $45.72M 10-K · filed 2016-02-29 | |
| 2013-09-30 | $11.46M 10-K · filed 2015-03-03 | $22.76M derived: sum of 2 quarters · filed 2015-03-03 | $33.82M 10-Q · filed 2014-11-10 | $45.11M derived: sum of 4 quarters · filed 2015-03-03 | |
| 2013-06-30 | $11.30M 10-K · filed 2015-03-03 | $22.35M 10-Q · filed 2014-07-31 | $33.65M derived: sum of 3 quarters · filed 2015-03-03 | $44.70M derived: sum of 4 quarters · filed 2015-03-03 | |
| 2013-03-31 | $11.06M 10-K · filed 2015-03-03 | $22.35M derived: sum of 2 quarters · filed 2015-03-03 | $33.40M derived: sum of 3 quarters · filed 2015-03-03 | $43.80M derived: sum of 4 quarters · filed 2015-03-03 | |
| 2012-12-31 | $11.30M 10-K · filed 2014-03-07 | $22.34M derived: sum of 2 quarters · filed 2014-03-07 | $32.75M derived: sum of 3 quarters · filed 2014-03-07 | $43.15M 10-K · filed 2015-03-03 | |
| 2012-09-30 | $11.04M 10-K · filed 2014-03-07 | $21.45M derived: sum of 2 quarters · filed 2014-03-07 | $31.85M 10-Q · filed 2013-11-05 | $42.20M derived: sum of 4 quarters · filed 2014-03-07 | |
| 2012-06-30 | $10.41M 10-K · filed 2014-03-07 | $20.81M 10-Q · filed 2013-08-01 | $31.16M derived: sum of 3 quarters · filed 2014-03-07 | $41.76M derived: sum of 4 quarters · filed 2014-03-07 | |
| 2012-03-31 | $10.40M 10-K · filed 2014-03-07 | $20.75M derived: sum of 2 quarters · filed 2014-03-07 | $31.35M derived: sum of 3 quarters · filed 2014-03-07 | $42.09M derived: sum of 4 quarters · filed 2014-03-07 | |
| 2011-12-31 | $10.35M 10-K · filed 2013-03-18 | $20.95M derived: sum of 2 quarters · filed 2013-03-18 | $31.68M derived: sum of 3 quarters · filed 2013-03-18 | $43.32M 10-K · filed 2014-03-07 | |
| 2011-09-30 | $10.60M 10-K · filed 2013-03-18 | $21.33M derived: sum of 2 quarters · filed 2013-03-18 | $32.97M 10-Q · filed 2012-11-09 | $44.92M derived: sum of 4 quarters · filed 2013-03-18 | |
| 2011-06-30 | $10.73M 10-K · filed 2013-03-18 | $22.37M 10-Q · filed 2012-08-07 | $34.32M derived: sum of 3 quarters · filed 2013-03-18 | $46.66M derived: sum of 4 quarters · filed 2013-03-18 | |
| 2011-03-31 | $11.64M 10-K · filed 2013-03-18 | $23.59M derived: sum of 2 quarters · filed 2013-03-18 | $35.93M derived: sum of 3 quarters · filed 2013-03-18 | $48.67M derived: sum of 4 quarters · filed 2013-03-18 | |
| 2010-12-31 | $11.95M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $24.29M derived: sum of 2 quarters · filed 2013-03-18 | $37.03M derived: sum of 3 quarters · filed 2013-03-18 | $49.69M 10-K · filed 2013-03-18 | |
| 2010-09-30 | $12.35M 10-Q · filed 2011-11-04 | $25.08M derived: sum of 2 quarters · filed 2011-11-04 | $37.75M 10-Q · filed 2011-11-04 | ||
| 2010-06-30 | $12.74M 10-Q · filed 2011-08-05 | $25.40M 10-Q · filed 2011-08-05 | |||
| 2009-12-31 | $46.84M 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |